MNCs Corner High-End Medical Device Market In China
This article was originally published in PharmAsia News
To boost domestic enterprises' R&D and speed to market, the China Association of Policy Science has established in Guangzhou a national research base for commercializing medical devices. It aims to effectively reduce the retail price of medical devices, cutting health care costs in the process. China's current medical device market of about 70 billion yuan is expected to expand to 120 billion yuan by 2010, making it the third largest worldwide market after the U.S. and Japan. However, 80 percent of local medical device manufacturers are small-to-mid-sized enterprises that clone or produce modified medical devices with low technology. MNCs still very much monopolize the high-end market for medical equipment such as CT and MRI diagnostic machines. (Click here for more)
You may also be interested in...
Laura Soucek, one of In Vivo’s 2020 Rising Leaders, is hoping to take Barcelona-based start-up Peptomyc to the next level. The company is nearing the clinic with an inhibitor of the transcription factor Myc, which is involved in the regulation of cellular proliferation, but can also be a driver of cancer.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
With some studies about to finish and others on clinical hold, the coronavirus vaccine field approaches an inflection point as the US FDA prepares for its first advisory committee on the topic. Our charts and graphics offer a quick look at what stands where.